New E. coli vaccine for cattle gets conditional USDA license
Willmar, Minn. -- Epitopix, the newest E. coli 0157 vaccine for cattle, was granted a conditional license by the U.S. Department of Agriculture.
Willmar, Minn.
-- Epitopix, the newest
E. coli
0157 vaccine for cattle, was granted a conditional license by the U.S. Department of Agriculture.
The vaccine is made with Epitopix's patented vaccine production process and is labeled for use in cattle to reduce E. coli 0157 carrier-state prevalence and to reduce the amount of the bacteria shed in feces, decreasing exposure among herds.
While the license is conditional, awaiting additional studies, the approval does allow Epitopix to make the drug immediately available, the company says. A similar drug, Econiche, was approved for use last year in Canada.
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
